Clinical Trial Update: An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients [Phase 4]

View source ↗

Summary

A Phase 4 open-label study evaluating the efficacy and tolerability of the Xanomeline/Trospium combination in patients with first-episode or early-phase schizop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Xanomeline/Trospium

Snippet

Sponsor: Vanguard Research Group | Conditions: Schizophrenia | Phase 4 | Status: NOT_YET_RECRUITING